Viewing Study NCT06224595


Ignite Creation Date: 2025-12-24 @ 2:14 PM
Ignite Modification Date: 2025-12-25 @ 7:18 PM
Study NCT ID: NCT06224595
Status: COMPLETED
Last Update Posted: 2024-12-03
First Post: 2024-01-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic Profiles and Food Effect of CS32582 Capsules
Sponsor: Chipscreen Biosciences, Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module